Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Get Thin MD vs Healthicare

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.9

Get Thin MD

Best for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available
★★★★4

Starting at $169/mo

CompoundedSemaglutideTirzepatideBrand
Visit Get Thin MD
7.1

Healthicare

Best for buyers who want a transparent, named-clinician + named-pharmacy compounded GLP-1 option in 44 states
★★★3.6

Starting at $148/mo

Compounded SemaglutideCompounded TirzepatideBrand OzempicBrand Wegovy
Visit Healthicare

Side-by-Side Comparison

FeatureGet Thin MDHealthicare
Overall Score7.9/107.1/10
Starting Price$169/mo$148/mo
Editorial Rating4 ★ /53.6 ★ /5
Features7 features7 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Get Thin MD

Pros

  • 3-month compounded semaglutide plan at $169/month is one of the lowest ongoing prices in the compounded GLP-1 category
  • Price-lock positioning: 'Same price, every dose. No hidden fees.' — per the product page
  • Both compounded and brand-name options available in one platform (compounded semaglutide, compounded tirzepatide, plus brand-name Ozempic and Zepbound where medically appropriate)
  • Nationwide availability with async evaluation — no in-person visit required
  • Broader wellness platform that also offers sermorelin, NAD+, HRT, and hair-loss treatments, so patients can consolidate multiple protocols with one provider
  • Proper FDA compounding disclaimer on the product page: "The FDA does not review or approve any compounded medications for safety or effectiveness."

Cons

  • Compounded medications are not FDA-approved as finished products and lack the formal safety/efficacy review of brand-name Ozempic, Wegovy, Zepbound, and Mounjaro
  • Pharmacy partners not publicly named on the site — no independent way to verify 503A/503B compounding source or per-batch testing
  • State-by-state availability claimed as nationwide but no verbatim state list is published — needs intake signup to confirm whether every state is actually served
  • Clinical efficacy headline ("9.6 pounds in 30 days") is based on 645 self-reported patient data points from Jan 2024 – Apr 2025 — self-reported data is lower-quality than a randomized trial
  • Broader wellness funnel (sermorelin + NAD+ + HRT alongside GLP-1s) means some patients may be upsold into off-weight-loss protocols — readers looking specifically for GLP-1 care should know the platform has a wider vertical mix

Healthicare

Pros

  • Both compounded and full brand-name GLP-1 menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
  • Pharmacy partner is publicly named: F&F Pharmacies Inc. dba Jungle Jim's Pharmacy, 5484 Dixie Highway, Fairfield, OH 45014, (877) 858-3784
  • Clinical lead is publicly named: Dr. Jonah Mink, 618.740.4204, Beluga Health
  • Compounded semaglutide first dose at $147.90/mo is on the lower end of the segment

Cons

  • Not available in 6 states: CA, NV, NJ, NC, TX, MA, MS, NH, WV, DE (verify the explicit list before sending readers)
  • Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above retail without insurance — most of the value here is on the compounded tier
  • Brand ownership: 'Sunshine Health Studios Inc.' is referenced in the footer — relationship to the healthicare.com domain owner needs independent confirmation

Our Verdict

Winner: Get Thin MDScore: 7.9/10

Get Thin MD edges out Healthicare with a higher overall score of 7.9/10 and is particularly strong for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available. Healthicare remains a solid alternative, especially if you're looking for buyers who want a transparent, named-clinician + named-pharmacy compounded GLP-1 option in 44 states.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.